Predictive value of D-Dimer and thromboplastin time as coagulation indicators for COVID-19 patients.

INTRODUCTION: Coronavirus 2019 symptoms include coagulopathy and thromboembolic risk. Using one parameter to diagnose coagulopathy has little predictive value. OBJECTIVE: This study will examine if D-dimer and APTT testing can predict COVID-19 severity and aid triage and manage patients. METHODS: 214 COVID-19 patients were enrolled and classified into two categories based on their respiratory manifestations; mild (126 cases) and severe (88 cases). Patient data regarding age, gender, D-Dimer level, and APTT level were collected. When both D-Dimer and APTT levels were abnormal, in this study, the patient was considered to have a coagulation disorder. Indicators of coagulation in the COVID-19 patients were collected and compared between the two groups. Chi-square (χ2) tests were used to determine the significant differences between coagulation disorders in the two groups. RESULTS: Our findings showed that patients with coagulopathies were more likely to belong to the severe group. Within the two groups of patients, the rate of coagulation disorders was as follows: mild = 8.8 % within coagulation disorders, 4.8% within the two Groups; severe = 91.2 % within coagulation disorders, 77.8 % within the two Groups. There was a statistically significant relationship between coagulation disorder and severe COVID-19 patients compared to mild patients (p < 0.05). CONCLUSIONS: Coagulation disorders are more likely to occur in severe COVID-19 patients. D-Dimer and APTT tests are significant indicators for predicting COVID-19 severity. Our research found an abnormal pattern of coagulation disorders and COVID-19 severity that should be considered in the COVID-19 treatment protocol.

Fe-nanoparticle effect on polypropylene for effective radiation protection: Simulation and theoretical study.

An evaluation of the gamma-neutron shielding capabilities of polymer nanocomposite materials based on polypropylene and iron nanoparticles is presented in this study. The chemical composition of the materials is (100-x) PP-Fex, (where x = 0.1, 0.3, 0.5, 1, 2 and 5 wt percent). For the proposed polymer samples with photon energies ranging from 30 to 2000 KeV, the mass attenuation coefficient (MAC), a crucial parameter for studying gamma-ray shielding capability, was calculated using the Geant4 Monte Carlo code. Results were compared with those predicted by EpiXS. The values of the Geant4 code and the EpiXS software were both found to be in excellent agreement. Using the mass attenuation coefficient values, we determined the linear attenuation coefficients, electron density, effective atomic number, and half value layer for all the samples. The shielding properties of the polymer samples were also evaluated by estimating both the fast neutron removal cross-section and the mean free path of the fast neutron at energies between 0.25 and 5.5 keV. The study's findings indicate a positive correlation between the Fe nanoparticle content and the gamma-ray shielding performance of PP-Fe polymer samples. Out of the several glasses that were evaluated, it was found that the PP-Fe5 polymer sample demonstrates the highest efficacy in terms of gamma-ray shielding. Moreover, the polymer sample PP-Fe5, which consists of 5 mol% of iron (Fe), exhibits the highest value of ∑R (1.10650 cm-1) and the lowest value of the mean free path for fast neutrons. This indicates that the PP-Fe5 possesses better gamma-neutron shielding efficiency.

Compatibility and Validation of a Recent Developed Artificial Blood through the Vascular Phantom Using Doppler Ultrasound Color- and Motion-mode Techniques.

BACKGROUND: Doppler technique is a technology that can raise the predictive, diagnostic, and monitoring abilities in blood flow and suitable for researchers. The application depends on Doppler shift (shift frequencies), wherein the movement of red blood cells away from the probe is determined by the decrease or increase in the ultrasound (US) frequency. METHODS: In this experiment, the clinical US (Hitachi Avious [HI] model) system was used as a primary instrument for data acquisition and test the compatibility, efficacy, and validation of artificial blood (blood-mimicking fluid [BMF]) by color- and motion-mode. This BMF was prepared for use in the Doppler flow phantom. RESULTS: The motion of BMF through the vessel-mimicking material (VMM) was parallel and the flow was laminar and in the straight form (regular flow of BMF inside the VMM). Moreover, the scale of color velocity in the normal range at that flow rate was in the normal range. CONCLUSION: The new BMF that is being valid and effective in utilizing for US in vitro research applications. In addition, the clinical US ([HI] model) system can be used as a suitable instrument for data acquisition and test the compatibility, efficacy, and validation at in vitro applications (BMF, flow phantom components).